The polarization of a neuron generally results in the formation of one axon and multiple dendrites, allowing for the establishment of neuronal circuitry. The molecular mechanisms involved in priming one neurite to become the axon, particularly those regulating the microtubule network, remain elusive. Here we report the identification of DOCK7, a member of the DOCK180-related protein superfamily, as a Rac GTPase activator that is asymmetrically distributed in unpolarized hippocampal neurons and selectively expressed in the axon. Knockdown of DOCK7 expression prevents axon formation, whereas overexpression induces formation of multiple axons. We further demonstrate that DOCK7 and Rac activation lead to phosphorylation and inactivation of the microtubule destabilizing protein stathmin/Op18 in the nascent axon and that this event is important for axon development. Our findings unveil a pathway linking the Rac activator DOCK7 to a microtubule regulatory protein and highlight the contribution of microtubule network regulation to axon development.
Introduction
Neurons are one of the most highly polarized cell types in nature. Typically, they polarize to elaborate one long axon and multiple, shorter dendrites so as to transmit and receive information and form circuitry (Craig and Banker, 1994) . How a neuron acquires and maintains its axon-dendrite polarity are enduring questions under intense investigation. A model system widely used for studying neuronal polarization is the primary culture of dissociated hippocampal neurons from rodents (Banker and Goslin, 1998) . These neurons polarize gradually in successive steps. Shortly after plating, a neuron attaches to the substratum and forms lamellipodia (stage 1), from which several minor neurites sprout (stage 2). After 24 hr, only one of these neurites elongates rapidly to form the axon (stage 3), whereas several days later the remaining neurites grow to form the dendrites (stage 4). In general, a neuron is considered polarized when the axon is distinct from the dendrites both in length and in composition of molecular markers. Significantly, recent in vivo studies and time-lapse analysis of living brain slices have revealed that developing hippocampal and cortical neurons undergo similar morphological changes during migration before becoming polarized, with ''multipolar'' cells extending several minor neurites during an intermediate stage (Nakahira and Yuasa, 2005; Noctor et al., 2004) .
The mechanisms underlying neuronal polarization are complex and involve integration of signals or cues that determine which neurite is to become the axon and that promote rapid neurite elongation and sustain axonal outgrowth. A number of studies proposed that enhancement of neurite elongation directs axon specification, since manipulations of neurite length can reset neurite competition, and exposure of a neurite to extracellular adhesion molecules, such as laminin, favors axon formation (Esch et al., 1999; Lamoureux et al., 2002) . A recent study, however, suggests that centrosome localization in the early postmitotic stage instructs where the axon will form and that axonal fate is determined entirely within the neuron (de Anda et al., 2005) . Notwithstanding, preferential localization or activation of the growth-promoting machinery in just one neurite of an unpolarized neuron is key in priming this neurite to become the axon. Intracellular mechanisms that enhance neurite/axon growth involve changes in both actin and microtubule (MT) networks. For instance, actin instability is highest in the neurite destined to become the axon, and locally destabilizing actin filaments can induce axon formation (Bradke and Dotti, 1999; Da Silva et al., 2005) . There is also a dramatic influx of MTs into the nascent axon that together with enhanced MT growth is believed to contribute to neurite/axon elongation (Baas, 2002; Yu and Baas, 1994; Yu et al., 2001) .
Several molecules linked to the regulation of the cytoskeleton have been implicated in different steps of neuronal polarization. When perturbing their functions, either longer, multiple, or no axons are formed, or the neurites lack axonal or dendritic qualities (reviewed in Arimura and Kaibuchi, 2005; Wiggin et al., 2005) . These molecules include the evolutionarily conserved Par3/ Par6/aPKC complex, the Akt/GSK-3b/CRMP-2 or APC complex, SAD kinases, Ras and Rho family members, and the membrane enzyme PMGS, which influences the activities of Rac and Rho GTPases Jiang et al., 2005; Kishi et al., 2005; Nishimura et al., 2005; Schwamborn and Puschel, 2004; Shi et al., 2003 Shi et al., , 2004 Yoshimura et al., 2005 ). Yet, asymmetric molecular localization in unpolarized stage 2 neurons has only been reported for PMGS, kinesin-1, Rap1b, and Rho family members, not for the other molecules or their associated activities Jacobson et al., 2006; Schwamborn and Puschel, 2004) .
Evidence has been provided that suggests that localized activation of Rac and concomitant inactivation of RhoA GTPases within one neurite of an unpolarized neuron contribute to axon formation by inducing actin instability . Of interest is that Rac, besides controlling the actin cytoskeleton, also regulates MT dynamics in nonneuronal cells. In particular, Rac promotes MT growth into the advancing lamellipodia of migrating cells (Wittmann et al., 2003) . This raises the question whether a distinctive Rac-mediated pathway triggers MT growth in the nascent axon, thereby contributing to its elongation. Thus far, little is known about the regulation of MT growth in the neurite destined to become the axon.
Here we report the identification of DOCK7, a previously uncharacterized member of the DOCK180-related protein superfamily, as an activator of Rac GTPases that is highly expressed in the developing brain. We demonstrate that DOCK7 is asymmetrically distributed in stage 2 hippocampal neurons and provide evidence that this protein plays a critical role in axon formation through Rac activation. We further show that DOCK7 mediates laminin-induced phosphorylation of the MT-destabilizing protein stathmin/Op18 and that the latter is important for the development of the axon. Our data delineate a pathway linking the Rac activator DOCK7 to a MT regulatory protein and support the idea that spatially controlled regulation of MT networks is important for axon formation and neuronal polarization.
Results

Identification of DOCK7 as an Activator of Rac GTPases
To search for upstream regulators of Rac GTPases involved in neuronal development, the yeast two-hybrid (YTH) approach was used to screen a human fetal brain cDNA library with the dominant-negative mutant form of Rac1 (Rac1N17) as bait. One of the positive clones contained a cDNA matching a C-terminally located sequence in the KIAA1771 clone (AB051558). The latter encodes a C-terminal fragment of DOCK7, a member of the DOCK180-related superfamily of proteins (also referred to as CZH proteins), which have emerged as novel activators of the Rho GTPases. This family contains at least 11 mammalian proteins, DOCK1 (=DOCK180)-DOCK11, and has members in many other eukaryotes (Cote and Vuori, 2002; Meller et al., 2005) . The YTH clone, referred to as DOCK7-C, showed strong binding to wild-type (wt) and dominant-negative mutant forms of Rac1 and the highly brain enriched Rac isoform Rac3, but only weak or no binding to the constitutively activated mutant forms of Rac1 and Rac3, respectively (Figure 1A) . No interaction was detected with wt or any of the mutant forms of Cdc42 or RhoA (data not shown).
The full-length DOCK7 cDNA clone was isolated (see Experimental Procedures) and contains an ORF of 6390 bp that encodes a protein with a predicted molecular mass of 241 kDa. BLAST searches and Pfam analysis with the full-length DOCK7 polypeptide sequence indicated that it is most homologous to the mammalian DOCK6 and DOCK8 family members and revealed two domains that are highly conserved throughout the DOCK180 superfamily: the catalytic DHR-2 domain (also termed Docker or CZH2 domain) and the DHR-1 (CZH1) domain ( Figure 1B ) (Brugnera et al., 2002; Cote and Vuori, 2002; Meller et al., 2005) . In contrast to the canonical Rho guanine nucleotide exchange factors (RhoGEFs), the DOCK180 family members do not contain the hallmark catalytic domain (Dbl homology-pleckstrin homology domain) that carries out the GEF activity. Instead, the DHR-2 domain of several DOCK180 family members has been shown to mediate the GDP-GTP exchange reaction of Rho proteins (Cote and Vuori, 2002; Meller et al., 2005) . A recent study indicated that the DHR-1 domain of DOCK180 binds PtdIns(3,4,5)P 3 (Cote et al., 2005) . No other recognizable motifs in DOCK7 were identified.
To determine whether full-length DOCK7 interacts with Rac proteins and whether this interaction is nucleotide dependent, lysates from N1E-115 neuroblastoma cells were incubated with GTPgS-loaded, GDPbSloaded, or nucleotide-free Rac1-or Rac3-GST fusion proteins immobilized on glutathione beads, and the bound proteins were analyzed by Western blotting using anti-DOCK7 polyclonal antibody. We found that DOCK7 associates with nucleotide-free, but not GDPbS or GTPgS-loaded, Rac1 and Rac3 proteins. No interaction was detected between DOCK7 and Cdc42 or RhoA proteins ( Figure 1C) . The association between nucleotidefree Rac proteins and DOCK7 also occurs in cells, as observed by immunoprecipitation studies of HEK293 cells expressing Flag-tagged DOCK7 and Myc-tagged Rac1 or Rac3 ( Figure 1D and data not shown).
The finding that DOCK7 specifically associates with nucleotide-free Rac proteins suggested a role for DOCK7 as an activator of Rac GTPases. To demonstrate that DOCK7 induces GTP loading of Rac in cells, we performed ''PBD pull-down assays.'' The premise of this assay is that the p21 Rac/Cdc42 binding domain (PBD) of PAK only binds to the active GTP-bound form of Rac. HEK293 cells were cotransfected with Myc-tagged Rac1 and full-length DOCK7, a C-terminal fragment of DOCK7 containing the DHR-2 domain (DOCK7-C, see Figure 1B ), or an empty control vector. Rac1-GTP was precipitated from cell lysates using the PBD of PAK1 fused to GST. We found that overexpression of DOCK7 or DOCK7-C significantly increases GTP loading of Rac1 compared to empty vector ( Figure 1E ). A DOCK7 deletion mutant (DOCK7DDHR-2) that lacks the DHR-2 domain and is defective in Rac1 binding failed to activate Rac1 in this assay (see Figure S1 in the Supplemental Data available online). Similarly, when Rac3 was coexpressed with full-length DOCK7 or DOCK7-C, we observed a 2.0-and 2.85-fold increase in GTPbound Rac3, respectively, whereas coexpressing DOCK7DDHR-2 had no effect. No increase in GTP-bound Cdc42 was detected when Cdc42 was coexpressed with either DOCK7 or DOCK7-C (data not shown).
Additional evidence that DOCK7 activates Rac proteins was provided by GDP release assays. Recombinant Rac1, Cdc42, and RhoA proteins fused to GST were loaded with [ 3 H] GDP and incubated with extracts from HEK293T cells expressing DOCK7-C, DOCK180-DHR-2 as a positive control, or an empty control vector. We observed that the GDP release rate from Rac1, but not from Cdc42 or RhoA, increased in the presence of DOCK7-C and DOCK180-DHR-2 containing extracts when compared to control vector extracts ( Figure 1F ). Taken together, our findings strongly suggest that DOCK7 is a GEF for Rac GTPases and that its DHR-2 domain likely carries out the GEF activity.
DOCK7 Is Highly Expressed in the Brain during Early Stages of Development
Among the identified DOCK180 family members, DOCK180 and DOCK2 have been studied most extensively. The ubiquitously expressed DOCK180 protein and its orthologs in Drosophila and C. elegans play crucial roles as upstream activators of Rac in actin cytoskeletal remodeling, cell migration, and phagocytosis (Gumienny et al., 2001; Kiyokawa et al., 1998; Nolan et al., 1998; Wu and Horvitz, 1998) . DOCK2, which is predominantly expressed in lymphocytes, plays a key role as a Rac activator in lymphocyte homing to lymphoid tissues (Fukui et al., 2001) . To date, however, nothing is known about the function of DOCK7, and the biological roles of its closest related family members, DOCK6 and DOCK8, are also largely unknown. We began the characterization of DOCK7 by determining its presence and distribution in the brain. Immunoblot experiments of postnatal day 5 (P5) rat tissues showed that DOCK7 protein levels were highest in the brain but were also detectable to variable extents in other tissues (Figure 2A) . DOCK7 was present in all major regions of P5 rat brain examined ( Figure 2B ). Furthermore, virtually all neuronal populations, including neurons of the hippocampus, stained positive for DOCK7 ( Figure 2G ). Interestingly, DOCK7 protein levels in the brain were higher at late embryonic and early postnatal days and then decreased gradually, but markedly, into adulthood ( Figure 2C ). Analysis using extracts from primary hippocampal cultures showed highest levels of DOCK7 protein 1 day after plating, when axons begin to emerge, and then a gradual decline at later stages ( Figure 2D ), suggesting a potential role for DOCK7 in axon development and neuronal polarization. In contrast, when we examined the protein levels of DOCK180 in hippocampal neurons, we observed low levels at early stages, which increased moderately at later stages ( Figure 2E ), questioning a prominent role for DOCK180 in axon development. Notably, RT-PCR and Northern blot analysis showed that DOCK6 and DOCK8 are only expressed at very low levels in the brain (Ruusala and Aspenstrom, 2004 , and data not shown).
Polarized Distribution of DOCK7 in Hippocampal Neurons
To assess a role for DOCK7 in neuronal polarity, we began by examining the localization of DOCK7 in hippocampal neurons during early stages of development. E18 rat hippocampal neurons were isolated, cultured on laminin, and stained with anti-DOCK7 antibody and phalloidin or one of the indicated antibodies at stages 1, 2, and 3 of neuronal development ( Figure 3A ). In stage 1 neurons, DOCK7 immunofluorescence was present throughout the cell body, but not in the actin-rich lamellipodial veil and filopodial extensions that surround the cell body, as judged by costaining with phalloidin (bottom panel, left). Noticeably, strong staining of DOCK7 around the cell periphery was observed ( Figure 3A) , which was most prominent on the basal side of the cell where the cell attaches the substrate (data not shown). In stage 2 neurons, DOCK7 was detected in the cell body and the multiple undifferentiated minor processes (neurites), which were visualized with the microtubule marker a-tubulin ( Figure 3A , top panel, left). Interestingly, we observed more prominent DOCK7 staining in only one of the multiple neurites for a significant number of unpolarized stage 2 neurons ( Figure 3A , arrows) (41.7% 6 6.1%, n = 46 versus 4.0% 6 2.8%, n = 50 using a control antibody; p < 0.02, c 2 test; the percentages represent stage 2 neurons that have in one neurite >1.5 times the fluorescence intensity of DOCK7 or control antibody than in any of the other neurites after normalization to the fluorescence intensity of a cytoplasmic volume marker; see Supplemental Data). To determine whether this neurite is the one that will become the axon, we analyzed the content of polymerized actin in the same cell. Previous studies have established that the neurite with the lowest actin filament content in its growth cone becomes the axon (Da . We found the highest levels of DOCK7 expression in the neurite with the lowest actin filament content (Figures 3B and 3C) . In polarized stage 3 neurons, we noted that DOCK7 was expressed abundantly in the longest neurite, which stained positive for Tau-1 (the axon), but was barely detectable in minor neurites that were labeled positive for MAP2 ( Figure 3A , right panel). No colocalization of DOCK7 with actin was observed at the periphery of the axonal growth cone; however, strong DOCK7 staining was noted in the shaft of the axon and in the proximal region of the growth cone where MTs are concentrated ( Figures 3A and 3D ). In contrast to DOCK7, we found that DOCK180 was uniformly distributed in the axon and the smaller processes in stage 3 neurons (data not shown). Thus far, only a few molecules have been reported to asymmetrically accumulate in a single neurite of unpolarized stage 2 neurons, with localization generally restricted to the tip of the neurite Jacobson et al., 2006; Schwamborn and Puschel, 2004) . Our data show that DOCK7 is preferentially expressed in the shaft and proximal region of the growth cone of one of the stage 2 neurites and that the polarized distribution of DOCK7 correlates with the formation of the axon. These results suggest a role for DOCK7 in the rapid elongation of the nascent axon.
DOCK7 Overexpression Induces the Formation of Multiple Axons
To test whether DOCK7 is important for axon formation, embryonic neurons in suspension were cotransfected with a GFP expression plasmid and a T7-tagged DOCK7 construct or a control vector. Approximately 45-52 hr after plating on coverslips coated with poly-L-lysine and laminin, the transfected neurons were stained with anti-Tau-1 and anti-MAP2 antibodies, and polarity was assessed for GFP-positive cells. We confirmed that all GFP-positive cells stained positive for the T7 epitope. In all of our experiments, an axon was defined as a long process (>70 mm in length) that expresses the axonal marker Tau-1, but not the dendritic marker MAP2. Cells with one long axon and multiple minor neurites were considered polarized neurons.
The control vector transfected neurons displayed normal polarity, with most of them having a single axon (>70 mm in length) that was rich in Tau-1 and multiple minor processes that were rich in MAP2 ( Figures  4A-4C ). In contrast, a large number of neurons expressing T7-tagged DOCK7 exhibited abnormal polarity. Instead of one single axon, they contained multiple axons that were >70 mm in length and enriched in Tau-1, but not in MAP2 (Figures 4A-4C ). All of these processes also stained positive for DOCK7. Expression of DOCK7 did not affect the total number of processes formed per cell compared to vector control transfected neurons ( Figure 4D ), indicating the formation of axons at the expense of dendrites. Thus, our data show that DOCK7 induces the formation of multiple axons and perturbs neuronal polarization. Notably, when culturing the DOCK7-expressing neurons until day 6, we observed that all axons were still enriched in Tau-1 ( Figure S2 ). We next tested the effects of coexpressing a dominant-negative mutant form of Rac3 (Rac3N17) or Rac1 (Rac1N17) with DOCK7 on the formation of multiple axons. We found that both Rac3N17 and Rac1N17 inhibit axon formation and interfere with the formation of multiple axons of DOCK7-expressing cells (Figures 4E-4G and data not shown). The majority of cells coexpressing DOCK7 and one of the dominant-negative Rac mutants exhibited minor neurites of similar length, but no axon. Furthermore, we found that expression of the DOCK7DDHR-2 mutant, which is defective in Rac binding and activation ( Figure S1 ), does not induce the formation of multiple axons ( Figures 4E-4G ). Interestingly, about 40% of these neurons displayed one axon, whereas more than 50% showed no axon. These data suggest that DOCK7DDHR-2 functions as a dominant-negative mutant. Our findings described above, together with our biochemical data, imply that DOCK7 promotes axon formation by acting on Rac GTPases.
DOCK7 Is Required for Axon Formation
To assess whether DOCK7 is required for neuronal polarization, we tested the effects of DOCK7 knockdown on axon formation using RNA interference (RNAi). Two hairpin-forming sequences were designed, one targeting the DOCK7 protein coding sequence (Dock7#1) and the other the 3 0 untranslated region (Dock7#2) of the mouse/rat DOCK7 mRNA, and the resulting oligonucleotides were cloned into the pSUPER vector (see Supplemental Data). Expression of either the Dock7#1 or Dock7#2 hairpin (hp) construct, but not a control hp construct, dramatically reduced DOCK7 levels in hippocampal neurons ( Figure 5B and Figure S3 ). The effect of DOCK7 knockdown on neuronal polarity was then assessed as described above. Most of the neurons transfected with the control hp construct displayed normal polarity, with one long axon and several minor processes ( Figures 5A and 5C ). In contrast, a significant number of neurons transfected with either pSUPERDock7#1 or pSUPER-Dock7#2 lacked a long Tau-1-positive axon but instead displayed multiple small processes ( Figure 5A ). The percentage of polarized Dock7#1 and Dock7#2 hp-expressing neurons was significantly lower compared to that of control hp-expressing neurons ( Figure 5C ). Expression of the Dock7 hp constructs did not affect the total number of processes formed per cell ( Figure 5D ) or the length of the minor neurites ( Figure 5E ). We next determined whether reintroduction of DOCK7 could rescue the loss of axon formation phenotype in neurons with reduced DOCK7 expression. To this end, we coexpressed full-length DOCK7 and the Dock7#2 hp construct that targets the 3 0 UTR. We observed that the levels of DOCK7 in neurons coexpressing DOCK7 and Dock7#2 hp were nearly similar to those of endogenous DOCK7 in control cells ( Figure S3 ). Most importantly, we found that the majority of these neurons displayed normal polarity, with a single long axon and multiple minor processes (Figures 5F and  5G) . Together, our data indicate that DOCK7 is required for axon formation and neuronal polarization.
DOCK7 Regulates Stathmin/Op18 Phosphorylation in Developing Neurons
What is the mechanism by which DOCK7 contributes to axon formation? We found no evidence to suggest that DOCK7 plays a prominent role in the regulation of the actin cytoskeleton. For instance, we did not observe colocalization of DOCK7 with actin at the periphery of the axon's growth cone. Moreover, in contrast to the Rac-GEF Tiam1/STEF (Nishimura et al., 2005) , DOCK7 staining was not observed in the lamellipodia of PDGFtreated NIH 3T3 cells, nor was lamellipodia formation seen in these cells upon DOCK7 expression (data not shown). However, in addition to its well-established role in actin remodeling, Rac has been shown to promote MT growth into advancing lamellipodia of migrating PtK1 epithelial cells (Wittmann et al., 2003) . Recent studies support the idea that Rac regulates leading-edge MT dynamics by locally enhancing stathmin/Op18 (Op18) phosphorylation at serine 16, thereby inactivating its MT-destabilizing activity (Daub et al., 2001; Wittmann et al., 2004) . Op18 is a ubiquitous phosphoprotein with tubulin-binding and MT-destabilizing activities, and it participates in the regulation of MT dynamics in vivo (Belmont and Mitchison, 1996; Curmi et al., 1999) . Like DOCK7, Op18 is highly expressed in developing neurons, including the hippocampus, and is strongly downregulated after synapse formation (Shumyatsky et al., 2005) .
These findings led us to investigate whether DOCK7 is involved in the regulation of Op18-S16 phosphorylation in developing hippocampal neurons and whether this event is important for axon formation. The amounts of phosphorylated Op18-S16 (Op18-S16-P) in neurons plated on poly-L-lysine-coated dishes layered with or without laminin were first determined by Western blot analysis with an antibody specific for the phosphorylated serine 16 form of Op18 (Gavet et al., 1998) . We found that the levels of Op18-S16-P were significantly higher when neurons were plated on laminin-coated dishes ( Figure 6A ). This is of interest given that laminin is known to promote axonal elongation and to trigger activation of Rac in several cell types (Esch et al., 1999; Gu et al., 2001) . We then examined whether DOCK7 knockdown and overexpression affects the levels of Op18-S16-P in neurons plated on laminin-coated dishes. The lentiviral vector pTRIPDU3-EF1a-EGFP (pTRIP) was used to deliver Dock7#1 and Dock7#2 hp RNA expression cassettes into hippocampal neurons at high efficiency (Janas et al., 2006) . Expression of Dock7#1 or Dock7#2 hp RNA, but not a control hp RNA, drastically reduced the levels of DOCK7 protein and, more importantly, diminished significantly the levels of Op18-S16-P ( Figures 6B and 6C) . The steady-state levels of Op18 protein in lysates from neurons expressing Dock7 hp RNAs and control hp RNA were essentially identical ( Figure 6B ). Similarly, we found that interfering with Rac function also decreased the levels of Op18-S16-P in hippocampal neurons (data not shown). Furthermore, we observed that ectopic expression of DOCK7, but not DOCK7DDHR-2, increased the levels of Op18-S16-P ( Figure 6D and 6E) . Thus, our data indicate that DOCK7, as an activator of Rac, is required for laminin-induced Op18-S16 phosphorylation in developing neurons.
We next assessed whether regulation of Op18-S16 phosphorylation is important for axon formation. To this end, we quantified the levels of Op18-S16-P in the developing axon and the future dendrites and examined the effects of ectopic expression of wt Op18 and an Op18-S16 phosphorylation-deficient mutant (Op18-S16A) on axon development. If S16 phosphorylation and concomitant inactivation of the MT-destabilizing activity of Op18 is important for axon formation, one would expect higher levels of Op18-S16 phosphorylation in the developing axon than in the future dendrites. Forty-five to sixty hours after plating E18 hippocampal neurons on laminin-coated coverslips, the fluorescence intensities of Op18-S16-P and total Op18 (relative to a cytoplasmic marker, CellTracker Green CMFDA) were measured proximally to the distal ends of the axons and the future dendrites ( Figure 7A ). We observed that in 82.5% of the neurons examined, the levels of Op18-S16-P were significantly higher in the developing axons than those in the future dendrites (p = 0.00004, sign test; n = 40; see Supplemental Data). However, no difference was observed for the intensities of total Op18 staining between the axons and the future dendrites (p = 0.1; n = 40) (see also Figure S4 ).
The effects of Op18 and Op18-S16A expression on neuronal polarity were examined as described for DOCK7. Notably, ectopic expression of wt stathmin/ Op18 molecules does not disrupt MTs in neuronal cells, . DOCK7 Mediates Laminin-Induced Op18-S16 Phosphorylation (A) Detergent extracts from hippocampal neurons cultured for 45-60 hr in dishes coated with or without laminin were probed with anti-Op18-S16-P antibody and antiOp18 Ab. (B and C) DOCK7 knockdown reduces Op18-S16 phosphorylation. (B) Neurons plated on laminin were transduced with pTRIP lentiviral vectors expressing Dock7#1, Dock7#2, control, or no (vector) hp RNA. Detergent extracts were probed with anti-DOCK7, anti-Op18-S16-P, anti-Op18, and anti-Erk2 Abs. (C) Fold decrease in Op18-S16-P levels. The data were normalized to total Op18 levels and then to a value of 1.0 for control hp (*p < 0.03 for Dock7#1 or Dock7#2 hp compared to control hp, t test; n = 3). (D and E) DOCK7 overexpression increases Op18-S16 phosphorylation. (D) Neurons plated on laminin were infected with recombinant adenoviruses expressing GFP (vector), T7-DOCK7 or T7-DOCK7DDHR-2. Blots were probed with anti-Op18-S16-P, anti-Op18, anti-b-tubulin, and anti-T7 antibodies. (E) Fold increase in Op18-S16-P levels. The data were normalized to total Op18 levels and then to a value of 1.0 for the control virus (*p < 0.03 for DOCK7 compared to control, t test; n = 3). Error bars indicate SEM.
as has been reported for nonneuronal cells (Gavet et al., 1998) . Whereas most of the control vector transfected neurons acquired normal polarity, we observed that expression of the wt Op18 construct somewhat reduced the number of polarized cells. However, this effect was moderate compared to cells expressing the Op18-S16A mutant (Figure 7B) , where a significant number of Op18-S16A-expressing neurons lacked a long axon. We then examined whether the Op18-S16A mutant can suppress the DOCK7-induced formation of multiple axons and found that this is indeed the case ( Figure 7C ). The majority of neurons coexpressing DOCK7 and Op18-S16A lacked an axon. These data imply that a significant fraction of Op18 molecules in the wt Op18-expressing neurons are phosphorylated and thus inactive, whereas the Op18-S16A molecules in Op18-S16A-expressing neurons cannot be phosphorylated and are always active. Hence, our findings suggest that the level of phosphorylated Op18-S16 downstream of DOCK7 activation is important for the development of the axon. We propose a model in which local DOCK7 activation causes an increase in Rac activity that triggers the phosphorylation and inactivation of Op18 in the nascent axon, thereby regulating MT dynamics/assembly and contributing to the elongation of the future axon. The kinase that mediates phosphorylation of Op18 downstream of Rac remains to be defined. In nonneuronal cells, the p21-activating kinase (PAK) was reported to be necessary but not sufficient for Rac-mediated Op18 phosphorylation and promotion of MT growth (Wittmann et al., 2004) . We found that interfering with PAK function (by expression of the PAK-autoinhibitory domain, AID-PAK) does not prevent axon formation nor DOCK7-induced multiple axon formation, suggesting the involvement of other kinases in neuronal cells ( Figure S5 ). Consistent with our findings, Drosophila Rac has been shown to control axon development through downstream effectors distinct from PAK (Ng et al., 2002; Kim et al., 2003) .
Discussion
Key events underlying axon development and neuronal polarization involve changes in both the actin and MT networks in the nascent axon. Recent studies have suggested that localized activation of a Rac-mediated pathway plays an important role in axon formation by controlling the actin cytoskeleton Nishimura et al., 2005) . In this report, we delineate a distinct pathway in which local activation of the GEF, DOCK7, regulates Rac activity to inactivate the MT-destabilizing protein stathmin/Op18 (Op18) and promote axon formation and neuronal polarization.
We identified DOCK7 as a putative activator of Rac GTPases in a YTH screen. DOCK7 belongs to an evolutionarily conserved protein superfamily with homology to DOCK180 that is comprised of at least 11 mammalian members, DOCK1 (DOCK180)-DOCK11 (Cote et al., 2005; Meller et al., 2005) . DOCK180, DOCK2, and DOCK3 (MOCA) have been shown to act as GEFs for Rac, whereas DOCK9 (Zizimin1) has been found to function as a GEF for Cdc42 (Brugnera et al., 2002; Fukui Figure 7 . Op18-S16 Phosphorylation Is Important for Axon Formation (A) Higher levels of Op18-S16-P are present in axons than in future dendrites. Stage 3 neurons plated on laminin were incubated with Cell Tracker Green CMFDA (lower panel) and then immunostained with anti-Op18-S16-P antibody or Op18 antibody. Scale bar, 20 mm. The histograms show the profiles of Op18-S16-P (left) and Op18 (right) immunofluorescence intensities in each of the numbered processes of the depicted stage 3 neurons (from the proximal to the distal end of the process) by ratio imaging against the cytoplasmic volume. The data shown are representative of more than 40 stage 2 neurons. (B) Percentage of polarized neurons ectopically expressing wt Op18, Op18-S16A mutant, or a control vector. Op18-S16A induces more severe polarity defects than wt Op18 (*p < 0.001 between Op18-S16A and vector, whereas p = 0.1 between wt Op18 and vector, c 2 test; n = 115 neurons for control vector, 112 for Op18-S16A, and 107 for wt Op18). (C) Op18-S16A inhibits the formation of multiple axons induced upon DOCK7 expression. Percentage of neurons with more that one axon is shown. (*p < 0.001, c 2 test; n = 55 neurons for each condition). Error bars in (B) and (C) indicate SEM. et al., Kiyokawa et al., 1998; Meller et al., 2002; Namekata et al., 2004) . These proteins have been implicated in actin remodeling and processes such as cell migration, cell-substratum adhesion, and apoptotic-cell engulfment. It is particularly interesting that DOCK180 and DOCK2 are involved in the directional migration of nonneuronal cells, a process that requires cell polarization, and that DOCK2 is involved in the regulation of T cell receptor polarization (Cote et al., 2005; Fukui et al., 2001; Gumienny et al., 2001; Sanui et al., 2003) . Up until now, nothing was known about the function of DOCK7. Our results demonstrate that DOCK7 associates with and activates Rac, but not Cdc42 or RhoA GTPases, and that DOCK7 is highly expressed in the developing brain. Most importantly, our data unveil a critical role for DOCK7 as a Rac-GEF in the early stage of axon formation. First, we show that DOCK7 is enriched in a single neurite of stage 2 hippocampal neurons and that it is selectively expressed in the axon of polarized stage 3 neurons, suggesting the involvement of DOCK7 in priming one neurite to become the axon. Second, ectopic expression of DOCK7 (but not DOCK7DDHR-2) in hippocampal neurons induces the formation of multiple axons, which can be suppressed by coexpression of dominant-negative mutant forms of Rac GTPases. Finally, we demonstrate that knockdown of DOCK7 in E18 hippocampal neurons prevents the formation of an axon. These results indicate that DOCK7 is required for axon formation and that other endogenously expressed DOCK180 family members cannot compensate for the lack of its function. Thus, our findings demonstrate a crucial role for DOCK7 in neuronal polarization and raise the possibility that DOCK180 family members function in general as key regulators of polarization in different types of cells.
A number of studies support the idea that, in addition to a dramatic influx of MTs into the nascent axon, dynamic reorganization of the MT network is important for axonal differentiation (Baas, 2002; Dent and Gertler, 2003; Yu et al., 2001) . However, the behavior of MTs and the molecular mechanisms regulating the MT network during early steps of axon formation remain largely elusive. Here we present data showing that DOCK7 and Rac control the phosphorylation of the MT-destabilizing protein Op18 on serine 16 in developing hippocampal neurons, with loss of either DOCK7 or Rac function significantly decreasing the levels of laminin-induced Op18-S16-P. While Op18 can be phosphorylated on up to 4 residues in response to extracellular stimuli or during mitosis, the phosphorylation of Op18 specifically at serine 16 by activated Rac is sufficient to inactivate its MT-destabilizing activities (Curmi et al., 1999; Daub et al., 2001; Rubin and Atweh, 2004; Wittmann et al., 2004) . Based on these findings and our observations that DOCK7 is concentrated in just one neurite of stage 2 neurons and is selectively expressed in the axon, we infer that DOCK7 locally triggers Op18-S16 phosphorylation through Rac activation to inactivate its MT-destabilizing capabilities in the nascent axon. Importantly, we also found that levels of Op18-S16-P (but not total Op18) are higher in the nearly formed axon than in the future dendrites and that expression of a phosphorylationdeficient Op18-S16A mutant significantly perturbs neuronal polarity, whereas wt Op18 does so only slightly, suggesting that local Op18-S16 phosphorylation is important for axon development. Moreover, we found that the Op18-S16A mutant blocks DOCK7-induced multiple axon formation. Thus, our data link local regulation of Op18 phosphorylation to axon development and implicate DOCK7 and Rac as critical regulators of this event. It is noteworthy that precedence for the importance of spatio-temporal regulation of Op18 phosphorylation comes from studies of mitotic and motile cells. In mitotic cells, local phosphorylation of Op18 has been shown to be required for mitotic spindle assembly (Niethammer et al., 2004; Rubin and Atweh, 2004) . In motile cells, this event correlates with the formation of a leading edge (Niethammer et al., 2004) .
Why would a developing neuron need an MT-destabilizing protein, and when and where would that neuron need to silence its activity? Evidence from mitotic cells indicates that the MT-destabilizing activity of Op18 is locally switched off by phosphorylation around chromosomes at the onset of mitosis, allowing MT polymerization and assembly of the mitotic spindle (Niethammer et al., 2004; Rubin and Atweh, 2004) . Since early stage hippocampal neurons express high levels of Op18, which is distributed throughout the cell, timed and local phosphorylation and inactivation of Op18 in the future axon may be important to suppress MT shrinkage and thus promote MT growth to facilitate fast elongation of the neurite/axon. With regards to enhanced MT growth in the developing axon, an EM study has shown that the length of an individual MT filament is longer in the developing axon than in the minor neurites (Yu and Baas, 1994) . It is therefore possible that the DOCK7-induced local inhibition of Op18 activity contributes to increased MT growth in the nascent axon and thereby facilitates and/or promotes axon formation. In support of a prominent role for Op18 in the development of neurons, knockdown of Op18 expression in Drosophila (which has a single Op18-related gene) results in neuronal migration and differentiation defects in the central and peripheral nervous system, including abnormalities in neurite/axon elongation (Ozon et al., 2002) . The lack of major developmental defects in Op18 knockout mice, however, is likely to reflect functional redundancy among the stathmin family members, including Op18, SCG10, SCLIP, and RB3 (Schubart et al., 1996) . DOCK7 may therefore influence the phosphorylation and activity of these molecules as well, since the serine 16 phosphorylation site is conserved among all members (Curmi et al., 1999) .
Our data support a model in which DOCK7 regulates MT stability in the nascent axon through Rac activation and consequently Op18 inactivation. However, regulation of MT network formation in the developing axon is a complex process that surely involves additional molecular players. For instance, a number of signaling molecules, such as GSK-3b and the PAR complex, which are abundantly expressed in the axon, have been linked to MT-binding proteins that regulate MT bundling, assembly, and/or stabilization (MAP1b, Tau, CRMP-2, and APC) and have been shown to play a role in axon formation and/or outgrowth (Jiang et al., 2005; Kishi et Previous studies have shown that phosphorylation of GSK3-b at Ser 9 inhibits its activity and that this event is important for axon formation (Jiang et al., 2005; Yoshimura et al., 2005) . We found, however, that knockdown of DOCK7 did not affect GSK-3b phosphorylation at Ser 9 ( Figure S6 ), implying that DOCK7 is not likely to influence axon formation by inhibiting GSK3-b activity through Ser 9 phosphorylation. In the future, it will be important to determine how all of these signaling pathways and mechanisms are integrated to mediate the development and growth of the axon. One plausible scenario is that local activation of DOCK7 in the future axon initiates MT growth through the phosphorylation and inactivation of Op18 molecules, while other protein complexes, including some of those mentioned above, enhance and/or sustain this growth by promoting MT stabilization. It is important to note that DOCK7-triggered MT growth may feed back on the actin cytoskeleton, given that growth of MTs has been reported to trigger actin remodeling in fibroblasts (Waterman-Storer et al., 1999) . Although we did not see major effects on the actin network, these observations do not exclude the possibility that DOCK7 affects actin dynamics.
How DOCK7 becomes concentrated in just one neurite of stage 2 neurons and is selectively expressed in the axon, but not the dendrites, is presently unknown. Presumably, this will involve directional protein transport in response to an extracellular cue. Of interest is our observation that DOCK7 accumulates at the basal side of the cell where the cell attaches the substrate. This localization pattern suggests a potential relationship between DOCK7 and extracellular matrix molecules, particularly between DOCK7 and laminin, which is known to influence and promote axon development (Esch et al., 1999) . In support of this, we observed a less severe polarity phenotype when hippocampal neurons ectopically expressing DOCK7 were plated on poly-L-lysine alone rather than on poly-L-lysine with laminin (data not shown). Moreover, we found that the S16-phosphorylation levels of Op18 are higher in neurons plated on dishes coated with laminin. How laminin influences the localization and/or activity of DOCK7 remains to be addressed. With regard to this, laminin has been shown to induce the production of PtdIns(3,4,5)P 3 in the developing axon, and DOCK180 becomes translocated to the plasma membrane of nonneuronal cells via direct binding of its DHR-1 domain, which is conserved in DOCK7, to PI 3-kinase generated PtdIns(3,4,5)P 3 (Cote et al., 2005; Menager et al., 2004) . Interestingly, we observed that inhibitors of PI 3-kinase abrogated the ability of DOCK7 to induce multiple axons ( Figure S7 ), which is consistent with a model in which PI 3-kinase-induced PtdIns(3,4,5)P 3 production is important for DOCK7 function in axon development. Further experiments, however, will be needed to substantiate this model. In summary, our findings not only offer insight into the function of the GEF DOCK7, showing that DOCK7 activates Rac GTPases and is critically involved in axon development, but also shed light on the regulation of MT networks as they pertain to the early steps of axon formation. Our data link DOCK7, which is asymmetrically distributed in stage 2 unpolarized neurons, and Rac activation to the local inactivation of the MT-destabilizing protein Op18. They further highlight the contribution of MT network regulation to the development of the axon by demonstrating a role for Op18 inactivation in this process. The identification of additional DOCK7-interacting proteins and elucidation of cross-talk with other MT regulatory pathways is necessary to fully decipher how the MT network is regulated to bring about neuronal polarization. Future studies involving real-time imaging of MT dynamics and growth during axon formation are also required to further reveal the contribution of these MT behaviors to this important developmental process in vivo.
Experimental Procedures
Yeast Two-Hybrid Screening 1 3 10 6 clones of a human fetal brain cDNA library in the pACT2 vector (Clontech) were screened using Rac1N17 cloned into pBMT116 as bait in the L40 yeast reporter strain (Van Aelst, 1998) .
DNA Constructs
Full-length human DOCK7 cDNA was obtained by PCR from a human Ntera2D1 cDNA library (gift from J. Skowronski) using 5 0 -TTTTGAGC TCCATGGCCGAGC GCCGCGCCTTCGCCCA-3 0 and 5 0 -TTTTGGTA CCAAGCGTTAACAATCTACATTTGATA TTTTC-3 0 primers (GenBank accession: DQ341187). The DOCK7 cDNA was then cloned into various expression vectors (see Supplemental Data for all constructs).
DOCK7 Antibody
The anti-DOCK7 antibody was raised in rabbits against a peptide corresponding to amino acids 132-151 of human DOCK7, which is conserved in the mouse and rat DOCK7 protein.
Cell Culture, Transfection, and Infection HEK293, HEK293T, and N1E-115 neuroblastoma cells were cultured in DMEM containing 10% fetal bovine serum. HEK293 and HEK293T cells were transfected using a calcium phosphate method. Primary hippocampal neuron cultures were prepared from E18 rat embryos as described (Pak et al., 2001) . The dissociated neurons were seeded on coverslips or dishes coated with a mixture of poly-L-lysine (40 mg/ml) and laminin (2.5 mg/ml) prepared in water. To assess the effect of laminin, neurons were plated on dishes first coated with poly-L-lysine (1 mg/ml) in borate buffer (pH 8.5) and then layered with 10 mg/ml laminin in PBS. Transfection of neurons was carried out immediately after dissociation using the Amaxa Nucleofector device (Amaxa GmbH). Three micrograms total of the indicated plasmids and 0.02 mg of pCAGGS-GFP were used per electroporation. Neurons were infected with lentiviruses or adenoviruses 3 hr after plating (see Supplemental Data).
Immunofluorescence and Imaging
Parasagittal frozen brain sections (10 mm) from P2 rats and dissociated hippocampal neurons were fixed with 3.5% paraformaldehyde, permeabilized with 0.2% Triton X-100 in PBS, and stained with indicated antibodies (see Supplemental Data). Images were acquired using an Axiovert 100M confocal laser scanning microscope (Zeiss) with a 633/1.40 Plan-Apochromat objective or an Axioskop 2 plus fluorescence microscope (Zeiss) with a 403/0.75 Plan-Neofluor objective. Data analysis is described in Supplemental Data.
Other Procedures
The methods for GST pull-down assays, coimmunoprecipitations, and guanine nucleotide exchange assays are described in Supplemental Data.
Supplemental Data
The Supplemental Data for this article include Supplemental Experimental Procedures and seven figures and can be found online at http://www.neuron.org/cgi/content/full/51/6/727/DC1/.
